MJardin Group, Inc. Stock Canadian Securities Exchange
Equities
MJAR
CA60689X1096
Pharmaceuticals
Sales 2019 | 26.7M 36.47M | Sales 2020 | 11.44M 15.62M | Capitalization | 3.41M 4.66M |
---|---|---|---|---|---|
Net income 2019 | -267M -365M | Net income 2020 | -34M -46.44M | EV / Sales 2019 | 5.55 x |
Net Debt 2019 | 134M 182M | Net Debt 2020 | 164M 224M | EV / Sales 2020 | 14.6 x |
P/E ratio 2019 |
-0.06
x | P/E ratio 2020 |
-0.1
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 92.27% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 21-05-25 |
Edward Jonasson
DFI | Director of Finance/CFO | 55 | 19-10-31 |
Patrick Witcher
BRD | Director/Board Member | - | 19-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 21-05-25 |
Blair Jordan
BRD | Director/Board Member | 55 | 21-05-25 |
James Lowe
BRD | Director/Board Member | - | 19-05-05 |
1st Jan change | Capi. | |
---|---|---|
+37.15% | 6.12B | |
-16.04% | 4.44B | |
-11.16% | 3.14B | |
-1.40% | 3.03B | |
+0.12% | 2.57B | |
+38.69% | 1.87B | |
+1.11% | 1.63B | |
-10.34% | 1.62B | |
-12.97% | 1.53B |